In-silico simulated prototype-patients using TPMS technology to study a potential adverse effect of sacubitril and valsartan-Reference-Cited by-同舟云学术

In-silico simulated prototype-patients using TPMS technology to study a potential adverse effect of sacubitril and valsartan

Published:2020-02-13 Issue:2 Volume:15 Page:e0228926
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Jorba Guillem,Aguirre-Plans Joaquim^ORCID,Junet Valentin,Segú-Vergés Cristina,Ruiz José Luis,Pujol Albert,Fernández-Fuentes Narcís,Mas José Manuel,Oliva Baldo^ORCID

Funder

Ministerio de Economía, Industria y Competitividad, Gobierno de España

Instituto de Salud Carlos III

H2020 Marie Skłodowska-Curie Actions

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference78 articles.

1. In silico clinical trials: concepts and early adoptions;F Pappalardo;Brief Bioinform,2018

2. Viceconti M, Clapworthy G. The virtual physiological human: Challenges and opportunities. 2006 3rd IEEE International Symposium on Biomedical Imaging: From Nano to Macro—Proceedings. 2006. pp. 812–815. doi:10.1109/isbi.2006.1625042

3. In silico clinical trials: how computer simulation will transform the biomedical industry;M Viceconti;Int J Clin Trials,2016

4. Anaxomics Biotech SL. TPMS technology [Internet]. 2018. Available: http://www.anaxomics.com/tpms.php

5. Unveiling the role of network and systems biology in drug discovery;A Pujol;Trends Pharmacol Sci,2010

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integration of expression datasets to identify biomarkers for accurate Gleason scoring in Prostate Cancer;2024-08-22

2. Machine Learning-Driven Biomarker Discovery for Skeletal Complications in Type 1 Gaucher Disease Patients;International Journal of Molecular Sciences;2024-08-06

3. Aflibercept Off-Target Effects in Diabetic Macular Edema: An In Silico Modeling Approach;International Journal of Molecular Sciences;2024-03-23

4. A quantitative systems pharmacology model for certolizumab pegol treatment in moderate-to-severe psoriasis;Frontiers in Immunology;2023-09-20

5. In silico evaluation of the role of lisdexamfetamine on attention-deficit/hyperactivity disorder common psychiatric comorbidities: mechanistic insights on binge eating disorder and depression;Frontiers in Neuroscience;2023-06-30